SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
Patent Extends Protection for its Novel Compounds and Methods Already granted in Australia and Japan TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), marks... Read more
Canntab Receives Medical Sales Licence from Health Canada
Ryan Allway November 11th, 2021 TORONTO, Nov. 11, 2021 /CNW/ – Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has received its medical sales license from Health Canada... Read more
BevCanna Sells Out Initial Shipment of Keef Brands, to British Columbia Liquor Distribution Branch
Ryan Allway November 8th, 2021 Demand for the award-winning beverage line prompts sell out of initial shipment online. VANCOUVER, British Columbia (Nov 8, 2021) — Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announced today that its initial shipment of... Read more
An Introduction to Topicals

A brief guide to learning more about topicals; what they are, how they work and what they are used for.

The post An Introduction to Topicals appeared first on The Cannifornian.

Read more
LUFF Announces Equity Financing
Ryan Allway September 2nd, 2021 Vancouver, B.C. – TheNewswire – September 2, 2021 – Luff Enterprises Ltd., (CSE:LUFF) (CNSX:LUFF.CN)  (“LUFF” or the “Company”) is pleased to announce its intention to raise up to $750,000 by way of a non-brokered private placement of 28,846,154 units at a price of $0.026 per unit (the “Private Placement”). Each Unit... Read more
Best Marijuana Stocks To Buy Now? 2 For Your List To Start September
Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now
SciSparc Announces Updates Regarding its Phase IIb Study in Tourette Syndrome
Ryan Allway July 26th, 2021 SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110 TEL AVIV, Israel, July 26, 2021 /PRNewswire/ — SciSparc Ltd. (OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced a number of updates regarding... Read more
Are These Top Marijuana Stocks On Your Watchlist Right Now? 2 Canadian Pot Stocks That Could Be Undervalued
Top Marijuana Stocks To Buy For The Long-Term? 2 Analyst Rate As A Strong Buy Right Now
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )